Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FSEZK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,716
Award facts
- Contract value 100% obligated
- $59,715.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $59,715.65 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills delivery orders through its DLA framework contract to supply medications and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Ondansetron is an antiemetic medication commonly used in medical settings to prevent nausea and vomiting, making it a standard pharmaceutical item within the military healthcare supply chain. The competitive award demonstrates the contractor's capability to meet federal procurement requirements and reflects the company's ongoing role as a primary supplier of pharmaceutical products across multiple therapeutic domains for the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FSEZK?
SPE2DB25FSEZK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FSEZK worth?
The government has obligated $59,716 on SPE2DB25FSEZK.
Is contract SPE2DB25FSEZK an order under another contract?
Yes. SPE2DB25FSEZK is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSEZK competed?
The extent of competition for SPE2DB25FSEZK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award